المؤلفون: Rollins G

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2002 Feb 22; Vol. 13 (4), pp. 1-2, 5.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Anti-Bacterial Agents*/economics , Anti-Bacterial Agents*/therapeutic use , Drug Utilization*/economics , Drug Utilization*/trends , Guideline Adherence*, Urinary Tract Infections/*drug therapy, Contraindications ; Drug Costs ; Drug Resistance, Bacterial ; Fluoroquinolones/economics ; Fluoroquinolones/therapeutic use ; Forecasting ; Humans ; Nitrofurantoin/economics ; Nitrofurantoin/therapeutic use ; Practice Guidelines as Topic ; Practice Patterns, Physicians' ; Trimethoprim, Sulfamethoxazole Drug Combination/economics ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; United States ; Urinary Tract Infections/economics

المؤلفون: Rollins G

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2004 Mar 19; Vol. 15 (6), pp. 1, 8-9.

نوع المنشور: Comparative Study; News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Respiratory Tract Infections*/blood , Respiratory Tract Infections*/drug therapy , Respiratory Tract Infections*/economics, Anti-Bacterial Agents/*therapeutic use , Bacterial Infections/*blood, Anti-Bacterial Agents/economics ; Bacterial Infections/drug therapy ; Biomarkers/blood ; Calcitonin/blood ; Contraindications ; Cost Savings ; Drug Resistance, Bacterial ; Humans ; Practice Guidelines as Topic ; Sensitivity and Specificity ; Switzerland ; Time Factors ; Treatment Outcome

المؤلفون: Levenson D

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2001 Apr 05; Vol. 12 (7), pp. 7-9.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Drug Resistance* , Respiratory Tract Infections*/therapy, Contraindications ; Humans ; Practice Guidelines as Topic ; United States

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2000 Aug 17; Vol. 11 (17), pp. 10, 12.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Drug Resistance, Microbial* , Evidence-Based Medicine* , Otitis Media*/drug therapy, Adolescent ; Child ; Child, Preschool ; Humans ; Infant ; Infant, Newborn ; Netherlands ; Practice Guidelines as Topic ; Treatment Outcome ; United States

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2000 Mar 30; Vol. 11 (7), pp. 8-10.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Drug Resistance, Bacterial* , Trimethoprim Resistance*, Ciprofloxacin/*therapeutic use , Pyelonephritis/*drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/*adverse effects, Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/therapeutic use ; Ciprofloxacin/economics ; Escherichia coli/drug effects ; Health Care Costs ; Humans ; Pyelonephritis/economics ; Trimethoprim, Sulfamethoxazole Drug Combination/economics ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use

المؤلفون: Levenson D

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2002 May 03; Vol. 13 (9), pp. 5-7.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Pneumonia*/drug therapy , Pneumonia*/mortality , Quality Indicators, Health Care*, Aged ; Anti-Bacterial Agents/therapeutic use ; Cell Culture Techniques ; Emergency Medical Services ; Emergency Service, Hospital ; Health Facility Size ; Hospital Mortality ; Hospitals/standards ; Hospitals, Teaching ; Humans ; Nursing ; Nursing Homes ; Patient Admission ; Practice Guidelines as Topic ; Time Factors ; United States ; Workforce ; Workload

المؤلفون: Levenson D

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2001 Dec 13; Vol. 12 (23), pp. 7-9.

نوع المنشور: Comparative Study; News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Frail Elderly* , Hospital Mortality* , Hospitalization* , Nursing Homes* , Pneumonia*/drug therapy , Pneumonia*/mortality , Pneumonia*/prevention & control, Aged ; Anti-Bacterial Agents/therapeutic use ; Humans ; Infusions, Intravenous ; Medicare/economics ; Models, Theoretical ; Outcome and Process Assessment, Health Care ; Risk Assessment ; Risk Factors ; United States ; Unnecessary Procedures

المؤلفون: Rollins G

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2001 Aug 09; Vol. 12 (16), pp. 5-7.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Ambulatory Care*/economics , Community-Acquired Infections*/diagnosis , Community-Acquired Infections*/economics , Community-Acquired Infections*/therapy , Hospitalization*/economics , Pneumonia*/diagnosis , Pneumonia*/economics , Pneumonia*/therapy , Practice Guidelines as Topic*, Anti-Bacterial Agents/therapeutic use ; Cost of Illness ; Disease Management ; Drug Resistance ; Humans ; Risk Factors ; United States

المؤلفون: Rollins G

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2000 Dec 18; Vol. 11 (24), pp. 1-2, 5.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Adrenal Cortex Hormones/*therapeutic use , Bronchodilator Agents/*therapeutic use , Pulmonary Disease, Chronic Obstructive/*therapy, Anti-Bacterial Agents/therapeutic use ; Evidence-Based Medicine ; Humans ; Positive-Pressure Respiration ; Practice Guidelines as Topic ; Pulmonary Disease, Chronic Obstructive/complications ; United States ; United States Agency for Healthcare Research and Quality

المؤلفون: Rollins G

المصدر: Report on medical guidelines & outcomes research [Rep Med Guidel Outcomes Res] 2000 Aug 31; Vol. 11 (18), pp. 6-7.

نوع المنشور: News

بيانات الدورية: Publisher: Health & Sciences Communications Country of Publication: United States NLM ID: 9106372 Publication Model: Print Cited Medium: Print ISSN: 1050-5636 (Print) Linking ISSN: 10505636 NLM ISO Abbreviation: Rep Med Guidel Outcomes Res

مواضيع طبية MeSH: Practice Guidelines as Topic* , Sinusitis*/diagnosis , Sinusitis*/drug therapy, Anti-Bacterial Agents/*therapeutic use, Adult ; Child ; Drug Resistance, Bacterial ; Humans ; United States